Ozempic Just Slowed Aging by 9% #longevity #antiaging

This week in longevity: a GLP-1 weight-loss drug (semaglutide) appears to have slowed biological aging by ~9% in a human trial — likely tied to visceral fat loss and reduced inflammation. Sam Altman-backed Retro Biosciences just hit a $1.8B valuation chasing 10 extra healthy years through cellular reprogramming, with its first human trial already underway. Follow for weekly evidence-based longevity news, and drop your questions below. SOURCES: Story 1 https://today.ucsd.edu/story/study-popular-glp-1-drug-may-slow-down-biological-aging Story 2 https://www.statnews.com/2026/05/22/retro-biosciences-longevity-valuation/ Story 3 https://www.fightaging.org/archives/2026/06/a-liver-aging-clock-predicts-all-cause-mortality/ Bonus Story https://www.fightaging.org/archives/2026/06/naked-mole-rats-exhibit-a-consistently-low-resting-metabolic-rate-with-aging/